NovoCure (NVCR) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, at the company's Jersey, Channel Islands office.

• Shareholders are invited to vote on key proposals, including director elections and compensation matters.

• Proxy materials are available online, with options for paper or email copies upon request before May 20, 2026.

Voting matters and shareholder proposals

• Election of eleven directors is proposed, with all nominees recommended by the board.

• Ratification of Kost Forer Gabbay & Kasierer (Ernst & Young Global) as auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay) is included.

• Approval of the amended and restated 2024 Omnibus Incentive Plan is up for vote.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Eleven director nominees are listed for election, including Asaf Danziger, William Doyle, and others.

• Board recommends voting in favor of all director nominees.